Phase I/II study of TH-302 in combination with pemetrexed in patients with solid tumors including NSCLC.
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2245229614
